Medical News

RSS

Some GOP lawmakers like their government health insurance

Seventeen new Republican lawmakers, almost one-fifth of the large House GOP freshman class, have rejected federal medical coverage for themselves and their families to highlight their opposition to President Barack Obama's showcase health insurance law.

23 Feb 2011

$Prolonged use of osteoporosis drugs may increase risk of unusual fractures in women$

Prolonged use of osteoporosis drugs may increase risk of unusual fractures in women

Women who take commonly prescribed drugs for osteoporosis known as bisphosphonates for five years or more may be at higher risk of certain kinds of fractures of their thigh bone, a new study has found.

23 Feb 2011

CAMH introduces mobile research lab to study mental health, addictions in communities across Ontario

Today, the Centre for Addiction and Mental Health launched Canada's first mobile research laboratory to study mental health and addictions in communities across Ontario.

23 Feb 2011

FDA grants 510(k) clearance to Vapotherm Flowrest homecare device

Vapotherm, the global leader in High Flow Therapy (HFT™) products, has received 510(k) clearance from the Food and Drug Administration (FDA) for the Flowrest® homecare device. The device also recently received CE marking.

23 Feb 2011

Regeneron submits VEGF Trap-Eye BLA to FDA for treatment of wet AMD

Regeneron Pharmaceuticals, Inc. announced that the company submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration (wet AMD). Under the Prescription Drug User Fee Act (PDUFA), the goal for a standard review time from submission to FDA action is ten months.

22 Feb 2011

Michael & Susan Dell Foundation grants $3.7 million to UTHealth for child obesity prevention, research

To continue their efforts to fight childhood obesity, The Michael & Susan Dell Center for Healthy Living, part of The University of Texas Health Science Center at Houston, has been awarded a four-year grant for $3.7 million grant from the Michael & Susan Dell Foundation.

22 Feb 2011

House votes to defund Planned Parenthood

On the same day as the House vote, the White House narrowed a Bush administration rule that allows medical providers to refuse to perform abortions.

22 Feb 2011

Claraview's Healthcare Analytics Solutions is now available for hospitals, clinics and health insurers

Claraview, a division of Teradata Corporation, a strategy and technology consultancy focused on business intelligence and analytics, today announced the availability of its Healthcare Analytics Solutions for hospitals, clinics, physician-practices, long-term care facilities, pharmacy benefit managers and health insurers.

22 Feb 2011

'Day on Deadly Killers'

Experts from Europe, the US and Asia will present their research results and discuss how new therapeutical approaches against infectious diseases may look like.

22 Feb 2011

Study: High-quality hospitals deliver lower-cost care to trauma patients

High-quality hospitals deliver lower-cost care to trauma patients, according to a study published in the Annals of Surgery.

22 Feb 2011

Canadian Intellectual Property Office grants patent to CardioGenics' QL Care Analyzer

CardioGenics Holdings Inc. announced today that it has been notified by the Canadian Intellectual Property Office that its patent application for the "core technology" utilized in its ultra-sensitive point-of-care immuno-analyzer, the QL Care Analyzer, has been granted. Patents covering the "core technology" have now been issued in Canada, the European Union and Japan.

22 Feb 2011

House passes FY11 budget bill

The House voted 235-189 on Saturday to pass legislation that "would fund government operations through Sept. 30, the end of fiscal 2011, while sharply reducing spending across a wide swath of federal agencies and programs," CQ reports. "Most spending levels under the bill would be based on fiscal 2010 levels, less eliminations, reductions and rescissions totaling roughly $61.5 billion. The measure would provide $99.6 billion less than President Obama sought for fiscal 2011," the news service writes (Weyl, 2/19).

22 Feb 2011

Researcher finds antibiotic in Eastern Red Cedar tree effective against MRSA

Most people would never suspect that a "trash tree," one with little economic value and often removed by farmers due to its ability to destroy farmland, could be the key to fighting a deadly bacterium. Now, a University of Missouri researcher has found an antibiotic in the Eastern Red Cedar tree that is effective against methicillin-resistant Staphylococcus aureus, a "superbug" that is resistant to most medications.

22 Feb 2011

Novartis FLUAD seasonal flu vaccine for older adults receives Health Canada approval

Health Canada has approved FLUAD, a Novartis seasonal flu vaccine for adults 65 years and older. Canadian seniors are the hardest hit of all age groups by seasonal influenza and account for 90 per cent of influenza deaths and 70 per cent of hospitalizations.

22 Feb 2011

NanoString launches fixed-panel assay product for human molecular karyotyping

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.

From NanoString Technologies 22 Feb 2011

TransPharma completes ViaDor-GLP1 agonist Phase 1b trial for treatment of type II diabetes

TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1b trial of ViaDor-GLP1 agonist, which is being developed for the treatment of diabetes mellitus type II.

22 Feb 2011

Researchers find endothelial dysfunction can predict risk of coronary heart disease

A new study from the Libin Cardiovascular Institute at the University of Calgary's Faculty of Medicine is shedding light on an underlying cause of heart disease.

22 Feb 2011

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer

Infinity Pharmaceuticals, Inc. today announced the initiation of the randomized Phase 2 portion of the trial of IPI-926 in combination with gemcitabine in patients with previously untreated, metastatic, pancreatic cancer.

22 Feb 2011

Gilead Sciences signs definitive agreement to acquire Calistoga for $375 million

Gilead Sciences, Inc. and Calistoga Pharmaceuticals, Inc., a privately-held biotechnology company focused on the development of medicines to treat cancer and inflammatory diseases, today announced the signing of a definitive agreement pursuant to which Gilead will acquire Calistoga for $375 million.

22 Feb 2011

Health Canada approves Orexo's Abstral to treat chronic cancer pain

Orexo AB today announces that ProStrakan's partner, Paladin Labs Inc. has been informed by Health Canada, the Canadian Government Department with responsibility for public health, that it has approved Abstral.

22 Feb 2011

Medical News

Some GOP lawmakers like their government health insurance

Prolonged use of osteoporosis drugs may increase risk of unusual fractures in women

CAMH introduces mobile research lab to study mental health, addictions in communities across Ontario

FDA grants 510(k) clearance to Vapotherm Flowrest homecare device

Regeneron submits VEGF Trap-Eye BLA to FDA for treatment of wet AMD

Michael & Susan Dell Foundation grants $3.7 million to UTHealth for child obesity prevention, research

House votes to defund Planned Parenthood

Claraview's Healthcare Analytics Solutions is now available for hospitals, clinics and health insurers

'Day on Deadly Killers'

Study: High-quality hospitals deliver lower-cost care to trauma patients

Canadian Intellectual Property Office grants patent to CardioGenics' QL Care Analyzer

House passes FY11 budget bill

Researcher finds antibiotic in Eastern Red Cedar tree effective against MRSA

Novartis FLUAD seasonal flu vaccine for older adults receives Health Canada approval

NanoString launches fixed-panel assay product for human molecular karyotyping

TransPharma completes ViaDor-GLP1 agonist Phase 1b trial for treatment of type II diabetes

Researchers find endothelial dysfunction can predict risk of coronary heart disease

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer

Gilead Sciences signs definitive agreement to acquire Calistoga for $375 million

Health Canada approves Orexo's Abstral to treat chronic cancer pain

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Latest News